Junevity
Junevity is a longevity biotechnology company developing Cell Reset therapeutics, a new class of medicines reversing transcriptional damage with siRNA. The RESET Platform is the first to use large-scale human data and AI to develop novel siRNA therapeutics targeting transcription factors. Founded out of UCSF in 2023, Junevity’s mission is to extend human lifespan and healthspan.
Junevity
I need information to perform this task.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
I need information to perform this task.
Service Requirements
I need information to perform this task.
Infrastructure Requirements
I need information to perform this task.
Talent Requirements
I need information to perform this task.
AI Insights
Growth Trajectory
I need information to perform this task.
Market Opportunity
I need information to perform this task.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats